Evidence map›Paper›PMID 30770834›Full record

ArticleNature communications2019

Phenazine production promotes antibiotic tolerance and metabolic heterogeneity in Pseudomonas aeruginosa biofilms.

Konstanze T Schiessl, Fanghao Hu, Jeanyoung Jo, Sakila Z Nazia, Bryan Wang, Alexa Price-Whelan, Wei Min, Lars E P Dietrich

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 261 citations in OpenAlex.

  1. Article
  2. CuBioactive materials · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. ClpP2 modulates ClpXP assembly to promote multiple pathogenic phenotypes inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. UnderstandingMicroorganisms · 2026
    Review
  18. Review
  19. Article
  20. Review

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Konstanze T SchiesslDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA.
Fanghao HuDepartment of Chemistry, Columbia University, New York, NY, 10027, USA.ORCID http://orcid.org/0000-0002-8659-4027
Jeanyoung JoDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA.
Sakila Z NaziaDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA.
Bryan WangDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA.
Alexa Price-WhelanDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA.
Wei MinDepartment of Chemistry, Columbia University, New York, NY, 10027, USA. wm2256@columbia.edu.ORCID http://orcid.org/0000-0003-2570-3557
Lars E P DietrichDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA. LDietrich@columbia.edu.ORCID http://orcid.org/0000-0003-2049-1137
Columbia University · US

Funding

CELLULAR AND MOLECULAR FOUNDATIONS OF BIOMEDICAL SCIENCET32GM008798 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PRYWES, RON M · 2001 to 2018
$6.3M
Integration of redox-balancing mechanisms in Pseudomonas aeruginosa biofilmsR01AI103369 · NIAID · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DIETRICH, LARS · 2013 to 2022
$4.1M
Optical imaging of small bio-molecules in living cells and tissues by nonlinear Raman microscopy coupled with vibrational tagsR01EB020892 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI MIN, WEI · 2015 to 2018
$1.3M
NIAID NIH HHS R01 AI103369NIBIB NIH HHS R01 EB020892NIGMS NIH HHS T32 GM008798
6 · The paper itself

Abstract

Antibiotic efficacy can be antagonized by bioactive metabolites and other drugs present at infection sites. Pseudomonas aeruginosa, a common cause of biofilm-based infections, releases metabolites called phenazines that accept electrons to support cellular redox balancing. Here, we find that phenazines promote tolerance to clinically relevant antibiotics, such as ciprofloxacin, in P. aeruginosa biofilms and that this effect depends on the carbon source provided for growth. We couple stable isotope labeling with stimulated Raman scattering microscopy to visualize biofilm metabolic activity in situ. This approach shows that phenazines promote metabolism in microaerobic biofilm regions and influence metabolic responses to ciprofloxacin treatment. Consistent with roles of specific respiratory complexes in supporting phenazine utilization in biofilms, phenazine-dependent survival on ciprofloxacin is diminished in mutants lacking these enzymes. Our work introduces a technique for the chemical imaging of biosynthetic activity in biofilms and highlights complex interactions between bacterial products, their effects on biofilm metabolism, and the antibiotics we use to treat infections.

Indexed as

Anti-Bacterial AgentsBiofilmsCiprofloxacinDrug Resistance, BacterialPhenazinesPseudomonas aeruginosaSpectrum Analysis, RamanAnti-Bacterial AgentsCiprofloxacinPhenazines

Identifiers

PMID30770834
PMCPMC6377615
OpenAlexW2912289068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.